| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/24/2008 | US7390519 Probiotic Lactobacillus salivarius strains |
| 06/24/2008 | US7390506 Substituted or unsubstituted 5-nitrothiazole covalently attached to a lipid selected from fatty acids or esters; oral administration; parasitic, bacterial, viral, or fungal infections; equine protozoal myeloencephalitis (EPM) or coccidiosis; drug delivery, nontoxic, bioavailability |
| 06/24/2008 | US7390502 Administering a mammalian host for treating a disease caused by proliferation of eukaryotic cells a formulation containing a complex of lipid and a drug 7-ethyl-10-hydroxycamptothecin |
| 06/24/2008 | US7390496 Therapeutic treatments for repetitive hand washing |
| 06/24/2008 | US7390495 Neurovirulent strain of the West Nile virus and uses thereof |
| 06/24/2008 | US7390494 Vaccine comprises nucleic acid encodes an immunogenic protein that induces a protective response effective against infection by a piglet weight loss disease circovirus; structural and non-structural polypeptides, vectors, and cells transformed by the vectors; kits for diagnosing |
| 06/24/2008 | US7390493 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 06/24/2008 | US7390492 Producing a passive immunity vaccine against Sarcocystis neurona by providing Sarcocystis neurona 16 kDa and 30 kDa antigens as determined by SDS polyacrylamide gel electrophoresis;immunizing mammal in mixture with adjuvant; removing serum; isolating antibodies; administering antibodies |
| 06/24/2008 | US7390491 Agents comprising midkine or an inhibitor thereof as active ingredient |
| 06/24/2008 | US7390490 Administering a monoclonal antibody that binds to CX3CR1 or fractalkine and inhibits chemotaxis of killer lymphocytes by suppressing an interaction between CX3CR1 and fractalkine; autoimmune diseases, diabetes, rheumatoid arthritis, and hepatitis |
| 06/24/2008 | US7390489 Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |
| 06/24/2008 | US7390487 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/24/2008 | US7390485 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders |
| 06/24/2008 | US7390483 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy |
| 06/19/2008 | WO2008074004A2 Human antibodies that bind cd70 and uses thereof |
| 06/19/2008 | WO2008073891A2 Salmonella vaccine in poultry |
| 06/19/2008 | WO2008073858A2 Cancer chemoprevention strategy based on loss of imprinting of igf2 |
| 06/19/2008 | WO2008073642A2 Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
| 06/19/2008 | WO2008073509A2 Compositions and methods for treating a neoplasm |
| 06/19/2008 | WO2008073490A1 Purification of influenza viral antigens |
| 06/19/2008 | WO2008073466A2 Alpha b-crystallin as a therapy for inflammation |
| 06/19/2008 | WO2008073464A2 Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| 06/19/2008 | WO2008073463A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | WO2008073333A2 Vaccine for periodontitis and methods of use |
| 06/19/2008 | WO2008073169A2 Methods, compositions and kits comprising attenuated anthrax vaccines and methods of delivery |
| 06/19/2008 | WO2008073160A2 Methods for converting or inducing protective immunity |
| 06/19/2008 | WO2008072903A1 Method of producing smallpox vaccine in the form of attenuated vaccinia virus using cell culture and smallpox vaccine produced using the method |
| 06/19/2008 | WO2008072895A1 Cell surface expression vector for liver cancer specific antigen alpha-fetoprotein and microorganism transformed by thereof |
| 06/19/2008 | WO2008072723A1 ANTI-Claudin-3 MONOCLONAL ANTIBODY, AND TREATMENT AND DIAGNOSIS OF CANCER USING THE SAME |
| 06/19/2008 | WO2008072000A2 Use of integrin alpha 10 binding antibody to modulate extracellular matrix ( cartilage) turnover |
| 06/19/2008 | WO2008071934A1 Treatment of cachexia |
| 06/19/2008 | WO2008071851A1 Polyvalent bioconjugates |
| 06/19/2008 | WO2008071701A1 Expression of transgenic t cell receptors in lak-t cells |
| 06/19/2008 | WO2008071394A1 Abeta antibody parenteral formulation |
| 06/19/2008 | WO2008070982A1 Archaeal polar lipid aggregates for administration to animals |
| 06/19/2008 | WO2008055069A3 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
| 06/19/2008 | WO2008051980A3 Methods of reducing phosphate absorption |
| 06/19/2008 | WO2008051245A3 Nanoparticles for use in immunogenic compositions |
| 06/19/2008 | WO2008045563A3 Modification of ionic strength in antibody-solutions to reduce opalescence/aggregates |
| 06/19/2008 | WO2008043777B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 06/19/2008 | WO2008020328A3 Manufacture of booster vaccines having reduced antigen doses |
| 06/19/2008 | WO2008017828A3 Antibodies specific for human cd98 heavy antigen |
| 06/19/2008 | WO2008008482A3 Altered br3-binding polypeptides |
| 06/19/2008 | WO2007146968A3 Single-chain multivalent binding proteins with effector function |
| 06/19/2008 | WO2007121447A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 06/19/2008 | WO2007109321A3 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 06/19/2008 | WO2007103814A8 Angiogenesis pathway gene polymorphisms for therapy selection |
| 06/19/2008 | WO2007099446A3 Virosome-like vesicles comprising gp41-derived antigens |
| 06/19/2008 | WO2007092427A3 Treatment of endotoxemia using endotoxin neutralizing agents |
| 06/19/2008 | WO2007070678A3 Rabies vaccine |
| 06/19/2008 | US20080147131 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 06/19/2008 | US20080146785 Antibody against tumor specific antigen as target |
| 06/19/2008 | US20080146508 Soluble cyclic analogues of beta amyloid peptide |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 06/19/2008 | US20080146488 strongly immunogenic polypeptide to a more weakly immunogenic polypeptide can precipitate and focus a CpG adjuvant to increase in vivo priming of a cytotoxic T-lymphocyte (CTL) response, and thus increase the immunogenicity of the more weakly immunogenic polypeptide |
| 06/19/2008 | US20080145916 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145441 Core of metal atoms of gold, silver or copper covalently linked to a carbohydrate group and to at least 20 ligands |
| 06/19/2008 | US20080145420 Multimeric immunoglobulin for use in prevention and treatment of viral and microorganismal infection |
| 06/19/2008 | US20080145406 Devices and methods for ophthalmic drug delivery |
| 06/19/2008 | US20080145387 N-(3-aminopropyl)-N,N-dimethyl-2,3-bis(-9-tetradeceneyloxy)-1 -propanaminium salt; cytofectin and lipid mixture |
| 06/19/2008 | US20080145385 Dna vaccine as immunoprophylaxis against kala-azar |
| 06/19/2008 | US20080145384 stimulating an immune response against a secreted enterohemorragic Escherichia coli (EHEC) antigen; cell culture supernatant is cultured under conditions that favor Type III antigen secretion; prevent infections |
| 06/19/2008 | US20080145383 Method for Solubilizing Peptide Mixtures |
| 06/19/2008 | US20080145382 (CTLA-4, Cytotoxic T-Lymphocyte Antigen-4); vaccines, feline immunomodulators, antitumor agents; treating feline viral diseases; veterinary medicine |
| 06/19/2008 | US20080145381 Multi-subtype FIV vaccines |
| 06/19/2008 | US20080145379 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 06/19/2008 | US20080145378 Means and Methods for Breaking Noncovalent Binding Interactions Between Molecules |
| 06/19/2008 | US20080145377 G-CSF Polypeptides And Uses Thereof |
| 06/19/2008 | US20080145376 Vectors And Methods For Genetic Immunization |
| 06/19/2008 | US20080145375 Vaccination |
| 06/19/2008 | US20080145374 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates |
| 06/19/2008 | US20080145373 Hepatitis B surface antigens; keyhole limpet hemocyanin; albumin; heat shock proteins |
| 06/19/2008 | US20080145372 Bioreductively-Activated Prodrugs |
| 06/19/2008 | US20080145371 SYNTHESIS OF HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES |
| 06/19/2008 | US20080145370 Multimeric immunoglobulin for use in prevention and treatment of viral and microorganismal infection |
| 06/19/2008 | US20080145369 Using pc-cell-derived growth factor concentration as diagnostic indicator of cell proliferative disorders |
| 06/19/2008 | US20080145368 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/19/2008 | US20080145367 Using interleukin specific immunoglobulin for treatment and prevention of imflammatory bone disorders |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145365 Human and mammalian stem cell-derived neuron survival factors |
| 06/19/2008 | US20080145364 Method for High Throughput Screening for Anitbodies and Proteins Inducing Apoptosis |
| 06/19/2008 | US20080145363 Using vascular endothelial growth factor specific immunoglobulin as tool in diagnosis, prevention and treatment of cell proliferative, respiratory, vision and inflammatory disorders |
| 06/19/2008 | US20080145362 Antibody combination useful for tumor therapy |
| 06/19/2008 | US20080145361 Uses of mammalian cytokine; related reagents |
| 06/19/2008 | US20080145360 Lysolipid specific immunoglobulin for use in diagnosis, prevention and treatment of blood and cell proliferative disorders |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145358 Method for Determining Responsiveness to Chk1 Inhibitors |
| 06/19/2008 | US20080145336 Use of isoindol-1-one or 1,3-dione compounds for treating cancer, angiogenesis inhibition or phosphodiesterase-4 inhibition; use with various other biodrugs and drugs |
| 06/19/2008 | US20080145335 Which protect neural cells from degeneration and/or death in response to injury or disease; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease |
| 06/19/2008 | US20080145333 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 06/19/2008 | US20080141936 Electrospraying apparatus and method for coating particles |
| 06/19/2008 | CA2708006A1 Cancer chemoprevention strategy based on loss of imprinting of igf2 |
| 06/19/2008 | CA2677688A1 Vaccine for periodontitis and methods of use |
| 06/19/2008 | CA2672703A1 Antibodies against human cytomegalovirus (hcmv) |
| 06/19/2008 | CA2672581A1 Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same |
| 06/19/2008 | CA2672468A1 Human antibodies that bind cd70 and uses thereof |